PERIPHERAL NEUROPATHY TREATMENT MARKET ANALYSIS

Peripheral Neuropathy Treatment Market, by Indication (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and others), by Treatment (Pharmacological Therapies(Pain Relievers, Anti-seizure Medications, Antidepressants) and Non-pharmacological Therapies (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange, and Others), by End User (Hospital, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI4363
Pages :212
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Peripheral Neuropathy Treatment Market: Restraint

The major factors that hinder growth of the global peripheral neuropathy treatment market include high cost of products and availability of alternative treatments and stringent regulatory compliance and device recalls. Some of the factors hampering the market growth are the increase in cost of the drugs used in the treatment of peripheral neuropathy and increasing availability of alternative therapies for the treatment of peripheral neuropathy. For instance, the availability of various other treatments such as radiotherapy and physiotherapy are considered more convenient and may lead to more better clinical outcomes for the patients.

Restraints & Challenges: